- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02573987
MEOPA Versus Local Anesthesia for Analgesia During Chorionic Villus Sampling. (MELIBIO)
January 4, 2018 updated by: Raoul Desbriere, Hospital St. Joseph, Marseille, France
MEOPA (Equimolar Mix of Oxygen and Nitrogen Monoxide) Versus Local Anesthesia for Analgesia During Chorionic Villus Sampling.
determine if efficiency of MEOPA anesthesia is at least equivalent to local anesthetics into the chorionic villus sampling in the first trimester of pregnancy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Compare anxiety discomfort and side effects
Study Type
Interventional
Enrollment (Actual)
192
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13008
- Hôpital St Joseph
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- pregnant
- 18 and over
- monofetal pregnancy
- chorionic villus sampling medical indication without contra indication
- informed consent signature
Exclusion Criteria:
- pregnant under 18
- multiple pregnancies
- pregnancy inferior 11 aw
- no informed consent signature
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Oxygen/nitrous oxide equimolar mix
96 participants undergoing chorionic villi sampling.
self administered inhalation of equimolar mixture of oxygen and nitrous oxide (MEOPA)
|
an experimental strategy inhalation by means of a breathing mask diffusing MEOPA
Other Names:
|
|
Active Comparator: Lidocaine
96 participants undergoing chorionic villi sampling infiltrative local anaesthesia of 1% lidocaine
|
standard strategy by local injection anesthesia of lidocaine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analgesia efficiency
Time Frame: 5 min after procedure
|
assessment of pain with visual analog scale
|
5 min after procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
assessment of anxiety
Time Frame: 5 min after biopsy
|
assessment of anxiety with visual analog scale
|
5 min after biopsy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raoul Desbriere, MD, Hôpital st Joseph Marseille France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2013
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
December 27, 2016
Study Registration Dates
First Submitted
September 17, 2015
First Submitted That Met QC Criteria
October 9, 2015
First Posted (Estimate)
October 12, 2015
Study Record Updates
Last Update Posted (Actual)
January 5, 2018
Last Update Submitted That Met QC Criteria
January 4, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, General
- Anesthetics
- Analgesics, Non-Narcotic
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Anesthetics, Inhalation
- Lidocaine
- Nitrous Oxide
Other Study ID Numbers
- A121414-31
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.